Literature DB >> 9135406

Bacteriology of lacrimal duct obstruction in adults.

J Hartikainen1, O P Lehtonen, K M Saari.   

Abstract

AIMS: To determine the current bacteriology of lacrimal duct obstruction (LDO) and to relate the bacteriological findings to the type of symptoms.
METHODS: 127 samples were obtained from the lacrimal sac in 118 consecutive adult patients with LDO, including nine bilateral cases.
RESULTS: Altogether, 156 isolates were recovered from the 127 samples cultured. Cultures were positive from 84% of the samples. Gram positive bacteria were isolated in 79 (62%) samples. The most frequently cultured bacterial species was Staphylococcus epidermidis, representing 27% of the isolates. Gram negative bacteria were recovered from 26 (20%) samples, and these bacteria were statistically significantly more common in cases with copious discharge than in cases with minor discharge (p = 0.000). Cases with simple stenosis of the lacrimal duct (SSLD) showed significantly less Streptococcus sp (p = 0.004) and Gram negative organisms (p = 0.004) than those with chronic dacryocystitis.
CONCLUSION: The bacteriology of SSLD resembles that of normal conjunctival flora. Chronic dacryocystitis in adults is associated with an increased proportion of Gram negative bacteria which may be a reservoir for postoperative intraocular infection. They should also be taken into account in selecting antimicrobial prophylaxis in lacrimal drainage surgery.

Entities:  

Mesh:

Year:  1997        PMID: 9135406      PMCID: PMC1721992          DOI: 10.1136/bjo.81.1.37

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

Review 1.  Acquired lacrimal drainage obstruction: an etiologic classification system, case reports, and a review of the literature. Part 1.

Authors:  G B Bartley
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1992       Impact factor: 1.746

2.  Bacteriology of the eye. I. Normal flora.

Authors:  L CASON; C H WINKLER
Journal:  AMA Arch Ophthalmol       Date:  1954-02

3.  Primary acquired nasolacrimal duct obstruction. A clinicopathologic report and biopsy technique.

Authors:  J V Linberg; S A McCormick
Journal:  Ophthalmology       Date:  1986-08       Impact factor: 12.079

4.  Clinical bacteriology of dacryocystitis in adults.

Authors:  D J Coden; A Hornblass; B D Haas
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1993-06       Impact factor: 1.746

5.  Aetiology and treatment of acute bacterial infection of the external eye.

Authors:  D V Seal; S P Barrett; J I McGill
Journal:  Br J Ophthalmol       Date:  1982-06       Impact factor: 4.638

6.  Bacterial flora of the normal conjunctiva. I. Topographical distribution.

Authors:  J A Fahmy; S Moller; M W Bentzon
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

7.  Lacrimal sac, conjunctival, and nasal culture results in dacryocystorhinostomy patients.

Authors:  J A Blicker; F V Buffam
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1993       Impact factor: 1.746

8.  Soft tissue infections after open lacrimal surgery.

Authors:  M J Walland; G E Rose
Journal:  Ophthalmology       Date:  1994-03       Impact factor: 12.079

9.  Acquired dacryocystitis: microbiology and conservative therapy.

Authors:  V Huber-Spitzy; F J Steinkogler; E Huber; E Arocker-Mettinger; M Schiffbänker
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-12

10.  [Normal flora of the human conjunctiva: examination of 135 persons of various ages].

Authors:  H J Thiel; U Schumacher
Journal:  Klin Monbl Augenheilkd       Date:  1994-12       Impact factor: 0.700

  10 in total
  23 in total

1.  Dacryocystitis: Systematic Approach to Diagnosis and Therapy.

Authors:  Sergio Pinar-Sueiro; Mercedes Sota; Telmo-Xabier Lerchundi; Ane Gibelalde; Bárbara Berasategui; Begoña Vilar; Jose Luis Hernandez
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

2.  Microbiologic spectrum of acute and chronic dacryocystitis.

Authors:  Bahram Eshraghi; Parisa Abdi; Mohammadreza Akbari; Masoud Aghsaei Fard
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Clinico-bacteriological study of chronic dacryocystitis cases in northern karnataka, India.

Authors:  Pradeep A V; Satish S Patil; S V Koti; Arunkumar J S; Santosh S Garag; Jyotirmay S Hegde
Journal:  J Clin Diagn Res       Date:  2013-11-10

4.  Pathological, immunohistochemical and microbiologicalal analysis of lacrimal sac biopsies in patients with chronic dacrocystitis.

Authors:  Rowayda Mahmoud Amin; Faten Aly Hussein; Hisham Farouk Idriss; Nesrine Fathy Hanafy; Dina Mohamed Abdallah
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

5.  Bilateral dacryoadenitis.

Authors:  Charlotte Derr; Ankit Shah
Journal:  J Emerg Trauma Shock       Date:  2012-01

6.  Value of microbiology study in congenital nasolacrimal duct obstruction.

Authors:  Yasser H Al-Faky; Tahir Naeem; Nora Al-Sobaie; Reem Al-Huthail; Hessa Al-Odan; Essam A Osman; Ahmad Mousa
Journal:  Saudi J Ophthalmol       Date:  2012-03-10

7.  External dacryocystorhinostomy outcomes in patients with a history of dacryocystitis.

Authors:  Daniel R Lefebvre; Sonya Dhar; Irene Lee; Felicia Allard; Suzanne K Freitag
Journal:  Digit J Ophthalmol       Date:  2015-09-20

8.  Granulicatella adiacens, an unusual causative agent in chronic dacryocystitis.

Authors:  Cristy A Ku; Blake Forcina; Paul Rocco LaSala; John Nguyen
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-04-14

9.  The microbiological profile of lacrimal abscess: two decades of experience from a tertiary eye care center.

Authors:  Mohammad Javed Ali; Swapna R Motukupally; Surbhi D Joshi; Milind N Naik
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-07-27

10.  Bacteriological profile and drug susceptibility patterns in dacryocystitis patients attending Gondar University Teaching Hospital, Northwest Ethiopia.

Authors:  Yared Assefa; Feleke Moges; Mengistu Endris; Banchamlak Zereay; Bemnet Amare; Damtew Bekele; Solomon Tesfaye; Andargachew Mulu; Yeshambel Belyhun
Journal:  BMC Ophthalmol       Date:  2015-04-02       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.